Drug Industry Antitrust Act, 87-1&2 PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Drug Industry Antitrust Act, 87-1&2 PDF full book. Access full book title Drug Industry Antitrust Act, 87-1&2 by United States. Congress. Senate. Judiciary. Download full books in PDF and EPUB format.
Author: United States. Congress. Senate. Judiciary
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 1928
Get Book Here
Book Description
Considers S. 1552 and companion H.R. 6245, the Drug Industry Antitrust Act, to amend the Federal Food, Drug, and Cosmetic Act and Sherman Antitrust Act to establish drug company licensing procedures, to require FDA to certify the effectiveness of all new drugs, to require advertisements sent to physicians to contain FDA warnings on the drug, and to limit drug company rights to exclusive production of patented drugs.
Author: United States. Congress. Senate. Judiciary
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 1928
Get Book Here
Book Description
Considers S. 1552 and companion H.R. 6245, the Drug Industry Antitrust Act, to amend the Federal Food, Drug, and Cosmetic Act and Sherman Antitrust Act to establish drug company licensing procedures, to require FDA to certify the effectiveness of all new drugs, to require advertisements sent to physicians to contain FDA warnings on the drug, and to limit drug company rights to exclusive production of patented drugs.
Author: United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust and Monopoly
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 1182
Get Book Here
Book Description
Considers S. 1552 and companion H.R. 6245, the Drug Industry Antitrust Act, to amend the Federal Food, Drug, and Cosmetic Act and Sherman Antitrust Act to establish drug company licensing procedures, to require FDA to certify the effectiveness of all new drugs, to require advertisements sent to physicians to contain FDA warnings on the drug, and to limit drug company rights to exclusive production of patented drugs.
Author: United States. Congress. Senate. Committee on the Judiciary
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 1366
Get Book Here
Book Description
Author: United States. Congress. House. Committee on the Judiciary
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 938
Get Book Here
Book Description
Committee Serial No. 32. Considers legislation to eliminate anticompetitive practices in the patenting, licensing, and marketing of drugs, and to require FDA standardization of drug names and stricter safety and efficacy standards for new drugs.
Author:
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages :
Get Book Here
Book Description
The amendments are also known as: Kefauver-Harris Drug Amendments.
Author: United States. Congress. House. Committee on the Judiciary
Publisher:
ISBN:
Category :
Languages : en
Pages : 934
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : Cosmetics
Languages : en
Pages : 916
Get Book Here
Book Description
Author:
Publisher: American Bar Association
ISBN: 9781604425628
Category : Antitrust law
Languages : en
Pages : 484
Get Book Here
Book Description
Author: United States
Publisher:
ISBN:
Category : Cosmetics
Languages : en
Pages : 804
Get Book Here
Book Description
Author: United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust and Monopoly
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 457
Get Book Here
Book Description
Considers S. 1552 and companion H.R. 6245, the Drug Industry Antitrust Act, to amend the Federal Food, Drug, and Cosmetic Act and Sherman Antitrust Act to establish drug company licensing procedures, to require FDA to certify the effectiveness of all new drugs, to require advertisements sent to physicians to contain FDA warnings on the drug, and to limit drug company rights to exclusive production of patented drugs.
